Status:

NOT_YET_RECRUITING

Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial

Lead Sponsor:

Fred Hutchinson Cancer Center

Collaborating Sponsors:

Merck Sharp & Dohme LLC

Conditions:

Human Papillomavirus-Related Carcinoma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This clinical trial compares usual care to interpersonal communication training and vaccination workflow training, alone or in combination, for improving communication about and recommendations for hu...

Detailed Description

OUTLINE: OBJECTIVE 1: Parents are randomized to receive messages on 1 of 6 topics. TOPIC I (SAFETY AND SIDE EFFECTS): Parents review 4 messages on safety and side effects and complete a survey over ...

Eligibility Criteria

Inclusion

  • OBJECTIVE 1: Adults aged 18 years or older who live in the 50 United States (U.S.) states and Washington District of Columbia (D.C.) and are parents or guardians of children ages 9-17 are eligible to take the national survey (n ≤ 1,600, with anticipated enrollment of n = \~1,500)
  • OBJECTIVE 2: Pharmacy staff at participating pharmacies (n ≤ 100)
  • OBJECTIVE 2: Adults aged 18 years or older whose children ages 9-17 received an HPV vaccine at one of the participating pharmacies in study year 2 (n ≤ 200)

Exclusion

  • OBJECTIVE 1: Non-English speaking as the survey is only available for this project in English
  • OBJECTIVE 1: Parents whose index children have completed the HPV vaccine series
  • OBJECTIVE 2: Non-English speaking as the study funding only provided resources for surveys and interview materials to be available in English
  • OBJECTIVE 2: Parents whose index children have completed the HPV vaccine series

Key Trial Info

Start Date :

March 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2027

Estimated Enrollment :

1900 Patients enrolled

Trial Details

Trial ID

NCT06926062

Start Date

March 1 2026

End Date

October 1 2027

Last Update

January 9 2026

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Penn State University

University Park, Pennsylvania, United States, 16802

2

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States, 98109